40 results
8-K
EX-99.1
d4h4ancvzavby1jomu
19 Apr 23
Results of Operations and Financial Condition
5:07pm
8-K
lgh6bdvp ieexyo
19 Apr 23
Results of Operations and Financial Condition
5:07pm
8-K
EX-99.1
b2bf48
2 Nov 22
Nevro Reports Third Quarter 2022 Financial Results, Narrows Full-Year 2022 Guidance and Raises Revenue Contribution from Painful Diabetic Neuropathy
4:14pm
8-K
EX-99.1
5nw8wk3dekky0zdm3
3 Aug 22
Nevro Reports Second Quarter 2022 Financial Results, Provides Third Quarter 2022 Guidance and Updates Full-Year 2022 Guidance
4:18pm
8-K
EX-99.1
gxtxsqf3qrjsc4j5uj0
4 May 22
Nevro Reports First Quarter 2022 Financial Results, Provides Second Quarter 2022 Guidance and Reiterates Full-Year 2022 Guidance
4:18pm
8-K
EX-99.1
srz3u
23 Feb 22
Nevro Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides First Quarter and Full-Year 2022 Guidance
12:00am
8-K
EX-99.1
6ilmolep3
10 Jan 22
Nevro Announces Preliminary, Unaudited Fourth Quarter and Fourth Quarter 2021 Worldwide Revenue of Approximately $102.5 Million
6:12am
8-K
EX-99.1
zhb6d v6f
8 Nov 21
Nevro Reports Third Quarter 2021 Financial Results and Provides Fourth Quarter Guidance
4:18pm